| Aspergillus fumigatus |
Aspergillus fumigatus |
Activity |
nan |
None |
10.1128/aac.01394-06 |
| Aspergillus fumigatus |
Aspergillus fumigatus |
IC50 |
0.015 |
ug.mL-1 |
10.1021/acs.jnatprod.9b00144 |
| Aspergillus fumigatus |
Aspergillus fumigatus |
MEC |
0.001 |
ug ml-1 |
10.1128/aac.01154-08 |
| Aspergillus fumigatus |
Aspergillus fumigatus |
MEC |
0.01 |
ug ml-1 |
10.1128/aac.01154-08 |
| Aspergillus fumigatus |
Aspergillus fumigatus |
MEC |
0.02 |
ug ml-1 |
10.1128/aac.01154-08 |
| Aspergillus fumigatus |
Aspergillus fumigatus |
MEC |
80.0 |
ug ml-1 |
10.1128/aac.01154-08 |
| Aspergillus fumigatus |
Aspergillus fumigatus |
MIC |
0.025 |
ug.mL-1 |
10.1016/j.bmcl.2017.04.004 |
| Aspergillus fumigatus |
Aspergillus fumigatus |
RFU |
2.909 |
None |
10.1128/aac.01394-06 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
IC50 |
0.005 |
ug.mL-1 |
10.1021/acs.jnatprod.9b00144 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Chlorocebus sabaeus |
Vero 76 |
IC50 |
100000.0 |
nM |
10.1016/j.bmcl.2017.04.004 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
FICI |
0.38 |
None |
10.1021/acs.jnatprod.9b00144 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
IC50 |
0.001 |
ug.mL-1 |
10.1021/acs.jnatprod.9b00144 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
0.01 |
ug.mL-1 |
10.1016/j.bmcl.2017.04.004 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
0.01 |
ug.mL-1 |
10.1021/acs.jmedchem.7b01413 |
| Equus caballus |
Ferritin light chain |
Potency |
15848.9 |
nM |
None |
| Equus caballus |
Ferritin light chain |
Potency |
31622.8 |
nM |
None |
| Gallus gallus |
Gallus gallus |
ED50 |
0.5 |
nM |
10.1021/jm980307x |
| Gallus gallus |
Serine-threonine protein phosphatase 2A regulatory subunit |
IC50 |
nan |
None |
10.1021/jm010066k |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
27230.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
7200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
3300.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
12200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
7180.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
40300.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
FC |
1.3 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
FC |
2.2 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A |
IC50 |
740.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A |
IC50 |
940.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A |
Ki |
360.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A |
Ki |
610.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
FC |
1.6 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
120.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
620.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
1000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
42.0 |
% |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
2660.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Kinact |
0.3 |
/min |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A4 |
Log 1/Km |
-0.792 |
None |
10.1016/j.bmcl.2005.06.015 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ratio IC50 |
5.0 |
None |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A5 |
IC50 |
140.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A5 |
IC50 |
630.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A5 |
Inhibition |
52.0 |
% |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A5 |
Inhibition |
nan |
% |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A5 |
Ki |
2690.0 |
nM |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A5 |
Kinact |
0.21 |
/min |
10.1124/dmd.111.043018 |
| Homo sapiens |
Cytochrome P450 3A5 |
Ratio IC50 |
5.0 |
None |
10.1124/dmd.111.043018 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
15003.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
19595.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
7488.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
FK506-binding protein 1A |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113160 |
| Homo sapiens |
FK506-binding protein 1A |
Activity |
nan |
None |
10.1021/acsmedchemlett.9b00144 |
| Homo sapiens |
FK506-binding protein 1A |
EC50 |
0.9 |
nM |
10.1016/s0960-894x(99)00336-4 |
| Homo sapiens |
FK506-binding protein 1A |
IC50 |
2.3 |
nM |
10.1021/jm980252z |
| Homo sapiens |
FK506-binding protein 1A |
IC50 |
2.5 |
nM |
10.1021/jm960066y |
| Homo sapiens |
FK506-binding protein 1A |
IC50 |
14.05 |
nM |
10.1016/j.bmcl.2017.04.004 |
| Homo sapiens |
FK506-binding protein 1A |
IC50 |
1000.0 |
nM |
10.1021/jm00137a004 |
| Homo sapiens |
FK506-binding protein 1A |
IC50 |
38290.0 |
nM |
10.1016/j.ejmech.2021.113160 |
| Homo sapiens |
FK506-binding protein 1A |
Inhibition |
nan |
% |
10.1016/j.bmcl.2017.04.004 |
| Homo sapiens |
FK506-binding protein 1A |
Inhibition |
nan |
% |
10.1021/acsmedchemlett.9b00144 |
| Homo sapiens |
FK506-binding protein 1A |
Kd |
0.2 |
nM |
10.1016/0960-894X(95)00404-H |
| Homo sapiens |
FK506-binding protein 1A |
Kd |
0.2 |
nM |
10.1016/S0960-894X(01)80992-6 |
| Homo sapiens |
FK506-binding protein 1A |
Kd |
0.4 |
nM |
10.1021/acs.jmedchem.6b00411 |
| Homo sapiens |
FK506-binding protein 1A |
Ki |
0.4 |
nM |
10.1021/jm980307x |
| Homo sapiens |
FK506-binding protein 1A |
Ratio |
1.0 |
None |
10.1021/jm3015052 |
| Homo sapiens |
FK506-binding protein 1A |
rIC50 |
1.0 |
None |
10.1016/s0960-894x(98)00702-1 |
| Homo sapiens |
FK506-binding protein 1A |
Selectivity |
5.2 |
None |
10.1021/jm960066y |
| Homo sapiens |
FK506-binding protein 1B |
Kd |
0.4 |
nM |
10.1021/jm500325k |
| Homo sapiens |
FK506 binding protein 4 |
Kd |
23.0 |
nM |
10.1021/acs.jmedchem.6b00411 |
| Homo sapiens |
GABA-B receptor 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
18837.5 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HepG2 |
IC50 |
100000.0 |
nM |
10.1016/j.bmcl.2017.04.004 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-19.9 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
8.37 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Activity |
2.05 |
ug ml-1 |
10.1128/aac.01096-07 |
| Homo sapiens |
Homo sapiens |
Activity |
4.2 |
ng/ml |
10.1128/aac.01096-07 |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1128/aac.01096-07 |
| Homo sapiens |
Homo sapiens |
AUC |
202.62 |
ng.hr.mL-1 |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
CL |
0.7 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
0.7 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.01 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.01 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Css |
0.011 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
5.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
15.0 |
% |
10.1021/jm400887j |
| Homo sapiens |
Homo sapiens |
F |
17.0 |
% |
10.1016/j.bmc.2007.08.060 |
| Homo sapiens |
Homo sapiens |
Fa |
0.15 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fabs |
25.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.15 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
1.03 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.97 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
IC50 |
0.23 |
nM |
10.1021/jm980252z |
| Homo sapiens |
Homo sapiens |
IC50 |
0.37 |
nM |
10.1016/s0960-894x(98)00145-0 |
| Homo sapiens |
Homo sapiens |
IC50 |
0.48 |
nM |
10.1021/jm960066y |
| Homo sapiens |
Homo sapiens |
Vdss |
1.2 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
HUVEC |
Activity |
nan |
None |
10.1021/acsmedchemlett.9b00144 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Jurkat |
IC50 |
360.0 |
nM |
10.1016/j.bmcl.2017.04.004 |
| Homo sapiens |
Jurkat |
IC50 |
5800.0 |
nM |
10.1021/acs.jnatprod.7b00269 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver microsome |
Drug metabolism |
nan |
None |
10.1124/dmd.111.039040 |
| Homo sapiens |
Liver microsome |
T1/2 |
0.04 |
hr |
10.1039/C2MD20266B |
| Homo sapiens |
Liver microsomes |
Stability |
nan |
% |
10.1021/jm0707424 |
| Homo sapiens |
Liver microsomes |
T1/2 |
1.0 |
hr |
10.1021/jm0707424 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
9439.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
PBMC |
IC50 |
0.29 |
nM |
10.1021/jm031101l |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase FKBP5 |
Kd |
104.0 |
nM |
10.1021/acs.jmedchem.6b00411 |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase FKBP5 |
Ki |
79.0 |
nM |
10.1021/acs.jmedchem.5b01355 |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase FKBP5 |
Ki |
80.0 |
nM |
10.1021/jm400087k |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase FKBP5 |
Ki |
93.0 |
nM |
10.1021/acs.jmedchem.6b00411 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/s0021-9258(18)53221-x |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1023/b:pham.0000026434.82855.69 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1067/mcp.2001.115142 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
Activity |
nan |
None |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
5000.0 |
nM |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
Efficacy |
60.9 |
% |
10.1124/dmd.110.035105 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
IC50 |
0.95 |
nM |
10.1021/jm031101l |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
IC50 |
3.162 |
nM |
10.1016/s0960-894x(00)00104-9 |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
14.8 |
nM |
10.1016/s0960-894x(99)00336-4 |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Kd |
20.0 |
nM |
10.1016/0960-894X(95)00404-H |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase PP1-gamma catalytic subunit |
IC50 |
nan |
None |
10.1021/jm010066k |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
17999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
23000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Skin |
Activity |
nan |
None |
10.1128/aac.00492-07 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
44999.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
IC50 |
3700.0 |
nM |
10.1007/s00210-003-0814-4 |
| Homo sapiens |
Splicing factor 3B subunit 3 |
Activity |
1.18 |
% |
10.1038/nchembio.2007.16 |
| Homo sapiens |
Splicing factor 3B subunit 3 |
Activity |
5.87 |
% |
10.1038/nchembio.2007.16 |
| Homo sapiens |
Splicing factor 3B subunit 3 |
IC50 |
10.9 |
nM |
10.1038/nchembio.2007.16 |
| Homo sapiens |
Splicing factor 3B subunit 3 |
IC50 |
13.8 |
nM |
10.1038/nchembio.2007.16 |
| Homo sapiens |
T-cell line |
Activity |
6.8 |
% |
10.1021/acs.jnatprod.6b00697 |
| Homo sapiens |
T-cell line |
Activity |
13.1 |
% |
10.1021/acs.jnatprod.6b00697 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
15340.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
2985.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
3349.8 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
CL |
0.014 |
mL.min-1.g-1 |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
CL |
0.018 |
mL.min-1.g-1 |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Km |
114000.0 |
nM |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Km |
126000.0 |
nM |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Vmax |
1.65 |
area/min/mg |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 1A4 |
Vmax |
2.23 |
area/min/mg |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Drug metabolism |
nan |
None |
10.1124/dmd.111.039040 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Km |
449000.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Vmax |
588.0 |
pmol/min/mg protein |
10.1016/j.pharmthera.2004.10.013 |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Issatchenkia orientalis |
ATP binding cassette transporter Abc1p |
Activity |
nan |
None |
10.1128/aac.01095-08 |
| Kluyveromyces marxianus |
Kluyveromyces marxianus |
Activity |
nan |
None |
10.1128/aac.01096-07 |
| Lichtheimia corymbifera |
Lichtheimia corymbifera |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00184-09 |
| Mucor circinelloides |
Mucor circinelloides |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00184-09 |
| Mus musculus |
4T1 |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114514 |
| Mus musculus |
Mus musculus |
Activity |
2.33 |
ug/g |
10.1021/jm0502384 |
| Mus musculus |
Mus musculus |
AUC |
1617.0 |
ng.hr.mL-1 |
10.1016/j.bmcl.2017.04.004 |
| Mus musculus |
Mus musculus |
CL |
29.5 |
mL.min-1.kg-1 |
10.1016/j.bmcl.2017.04.004 |
| Mus musculus |
Mus musculus |
ED50 |
0.22 |
mg.kg-1 |
10.1016/s0960-894x(99)00336-4 |
| Mus musculus |
Mus musculus |
ED50 |
0.24 |
mg.kg-1 |
10.1016/s0960-894x(98)00397-7 |
| Mus musculus |
Mus musculus |
ED50 |
2.6 |
mg.kg-1 |
10.1016/s0960-894x(98)00397-7 |
| Mus musculus |
Mus musculus |
ED50 |
2.6 |
mg.kg-1 |
10.1016/s0960-894x(99)00336-4 |
| Mus musculus |
Mus musculus |
ED50 |
3.5 |
mg.kg-1 |
10.1016/s0960-894x(98)00397-7 |
| Mus musculus |
Mus musculus |
IC50 |
0.2 |
nM |
10.1016/s0960-894x(99)00336-4 |
| Mus musculus |
Mus musculus |
IC50 |
0.29 |
nM |
10.1016/S0960-894X(01)80265-1 |
| Mus musculus |
Mus musculus |
Inhibition |
53.0 |
% |
10.1016/j.bmcl.2016.01.019 |
| Mus musculus |
Mus musculus |
rIC50 |
1.0 |
None |
10.1016/s0960-894x(98)00702-1 |
| Mus musculus |
Mus musculus |
T1/2 |
0.952 |
hr |
10.1016/j.bmcl.2017.04.004 |
| Mus musculus |
Mus musculus |
Vdss |
1.8 |
L.kg-1 |
10.1016/j.bmcl.2017.04.004 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
11220.2 |
nM |
None |
| Mus musculus |
P-glycoprotein 3 |
Activity |
nan |
None |
10.1023/a:1018993312773 |
| Mus musculus |
P-glycoprotein 3 |
Activity |
nan |
None |
10.1046/j.1440-1681.2000.03308.x |
| Mus musculus |
Plasma |
Ratio AUC |
8.2 |
None |
10.1124/dmd.110.034629 |
| Mus musculus |
Splenocyte |
Inhibition |
83.0 |
% |
10.1021/acs.jnatprod.0c00558 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1900.0 |
nM |
10.1021/acsmedchemlett.0c00272 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1510.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1694.4 |
nM |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cortical neurone |
Activity |
nan |
None |
10.1021/jm0707424 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Activity |
nan |
None |
10.1124/dmd.110.035105 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
361.3 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.01 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
290.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
303.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
309.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
348.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
33.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
41.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
50.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
51.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
56.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
67.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
75.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
80.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Axonal regeneration rate |
16.0 |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
Axonal regeneration rate |
29.0 |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
Axonal regeneration rate |
34.0 |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
Axonal regeneration rate |
nan |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
20.0 |
mg dl-1 |
10.1016/s0960-894x(98)00397-7 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
22.0 |
mg dl-1 |
10.1016/s0960-894x(98)00397-7 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
43.0 |
mg dl-1 |
10.1016/s0960-894x(98)00397-7 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
76.0 |
mg dl-1 |
10.1016/s0960-894x(98)00397-7 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
163.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
170.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
183.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
790.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
810.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
923.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
933.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
136.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
194.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
220.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
231.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Cmax |
29.85 |
nM |
10.1021/jm00008a001 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
31670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.4 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.6 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ED100 |
3.0 |
mg kg-1 |
10.1021/jm00008a001 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.1 |
mpk/d |
10.1021/jm960066y |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.15 |
mg.kg-1 |
10.1016/s0960-894x(98)00145-0 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.15 |
mg kg-1 day-1 |
10.1021/jm980252z |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.3 |
mg.kg-1 |
10.1021/jm031101l |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.6 |
mg.kg-1 |
10.1021/jm00008a001 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.9 |
mg.kg-1 |
10.1021/jm00008a001 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
3.0 |
mg.kg-1 |
10.1021/jm031101l |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
3.7 |
mg.kg-1 |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
10.0 |
mg.kg-1 |
10.1021/jm031101l |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
104.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
115.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
128.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1493.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1563.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1640.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
2073.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.97 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.53 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
36.57 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.9 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
139700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
141000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
151700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
71.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
133.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
171.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
188.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12942.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
13422.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
15415.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
15984.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
86.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
89.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
93.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.73 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.77 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.37 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
382700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
385700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
399700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
400000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.4 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.9 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.53 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.77 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Mean axonal area |
67.0 |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
Mean axonal area |
83.0 |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
Mean axonal area |
100.0 |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
Mean axonal area |
120.0 |
None |
10.1021/jm980307x |
| Rattus norvegicus |
Rattus norvegicus |
MND |
12.0 |
14-21 day |
10.1021/jm00008a001 |
| Rattus norvegicus |
Rattus norvegicus |
MND |
52.0 |
14-21 day |
10.1021/jm00008a001 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
63.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
64.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
188.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
191.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MST |
6.5 |
day |
10.1016/j.bmc.2016.08.007 |
| Rattus norvegicus |
Rattus norvegicus |
Nephrotoxicity |
13.0 |
ng ml-1 |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
Nephrotoxicity |
18.1 |
mg dl-1 |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
Nephrotoxicity |
21.0 |
mg dl-1 |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
Nephrotoxicity |
26.0 |
mg dl-1 |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
Nephrotoxicity |
45.0 |
ng ml-1 |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
Nephrotoxicity |
611.0 |
ng ml-1 |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
Nephrotoxicity |
nan |
None |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
5.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
11.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
914.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1386.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1663.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1684.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
120.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
126.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
127.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
132.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1252330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1336000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1427670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1434330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.78 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.35 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.36 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.77 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
60700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5730000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5880000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5950000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6230000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
45.0 |
% |
10.1016/s0960-894x(99)00336-4 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
142.57 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.37 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.97 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
147.07 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
16.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Walking behaviour |
100.0 |
% |
10.1021/jm991038t |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14930.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
15000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
17070.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
17270.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Weight difference |
18.0 |
% |
10.1021/jm991038t |
| Rattus norvegicus |
RBL-2H3 |
IC50 |
0.25 |
nM |
10.1016/j.bmcl.2006.07.068 |
| Rattus norvegicus |
RBL-2H3 |
IC50 |
0.25 |
nM |
10.1016/j.bmcl.2012.02.034 |
| Rattus norvegicus |
RBL-2H3 |
IC50 |
0.25 |
nM |
10.1016/j.bmcl.2013.05.093 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rhizopus arrhizus |
Rhizopus arrhizus |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00184-09 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
5.536 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.3285 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.02 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
3.58 |
% |
10.21203/rs.3.rs-23951/v1 |
| Trichophyton mentagrophytes |
Trichophyton mentagrophytes |
Activity |
nan |
None |
10.1128/aac.00492-07 |
| Trichophyton mentagrophytes |
Trichophyton mentagrophytes |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00492-07 |
| Trichophyton mentagrophytes |
Trichophyton mentagrophytes |
MIC80 |
1.0 |
ug.mL-1 |
10.1128/aac.00492-07 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114514 |
| None |
ADMET |
CL |
0.001 |
mL.min-1.g-1 |
10.1124/dmd.111.039040 |
| None |
ADMET |
CL |
0.018 |
mL.min-1.g-1 |
10.1124/dmd.111.039040 |
| None |
ADMET |
CL |
0.03 |
mL.min-1.g-1 |
10.1124/dmd.111.039040 |
| None |
ADMET |
CL |
0.7 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1124/dmd.111.039040 |
| None |
ADMET |
IC50 |
0.06 |
nM |
10.1021/jm031101l |
| None |
ADMET |
IC50 |
0.18 |
nM |
10.1021/jm031101l |
| None |
ADMET |
Km |
51800.0 |
nM |
10.1124/dmd.111.039040 |
| None |
ADMET |
Km |
91000.0 |
nM |
10.1124/dmd.111.039040 |
| None |
ADMET |
Km |
101000.0 |
nM |
10.1124/dmd.111.039040 |
| None |
ADMET |
MRT |
27.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Off-rate |
15.1 |
min |
10.1021/jm9806042 |
| None |
ADMET |
Papp |
0.7 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
1.0 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
3.6 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
permeability |
18.0 |
10^-6 cm/s |
10.1021/acs.jmedchem.1c01687 |
| None |
ADMET |
Ratio |
-1.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.7 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
3.5 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
80.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
81.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
T1/2 |
0.3683 |
hr |
10.1039/C2MD20266B |
| None |
ADMET |
T1/2 |
26.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Therapeutic index |
2.0 |
14 day |
10.1021/jm00008a001 |
| None |
ADMET |
Therapeutic index |
15.0 |
None |
10.1016/s0960-894x(98)00397-7 |
| None |
ADMET |
TI |
2.0 |
None |
10.1021/jm00008a001 |
| None |
ADMET |
Vdss |
1.2 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vmax |
0.04 |
area/min/mg |
10.1124/dmd.111.039040 |
| None |
ADMET |
Vmax |
1.65 |
area/min/mg |
10.1124/dmd.111.039040 |
| None |
ADMET |
Vmax |
3.14 |
area/min/mg |
10.1124/dmd.111.039040 |
| None |
CD4+ve Th |
IC50 |
0.034 |
nM |
10.1021/acs.jnatprod.0c00767 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
7.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LTKB_BD DILI severity score |
5.0 |
None |
10.1016/j.drudis.2011.05.007 |
| None |
NON-PROTEIN TARGET |
Fu |
0.01 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
37.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
1.5e-05 |
ug.mL-1 |
10.1021/np010152n |
| None |
NON-PROTEIN TARGET |
IC50 |
1.5e-05 |
ug.mL-1 |
10.1021/np0302201 |
| None |
NON-PROTEIN TARGET |
IC50 |
0.0016 |
ug.mL-1 |
10.1021/np010152n |
| None |
NON-PROTEIN TARGET |
IC50 |
0.0016 |
ug.mL-1 |
10.1021/np0302201 |
| None |
NON-PROTEIN TARGET |
MIC |
4.0 |
ug.mL-1 |
10.1128/aac.00184-09 |
| None |
No relevant target |
LogD6.5 |
4.36 |
None |
10.1016/s0960-894x(98)00145-0 |
| None |
No relevant target |
LogD7.4 |
4.38 |
None |
10.1016/s0960-894x(98)00145-0 |
| None |
No relevant target |
Solubility |
1.0 |
ug.mL-1 |
10.1016/s0960-894x(98)00145-0 |
| None |
No relevant target |
Solubility |
1.3 |
ug.mL-1 |
10.1021/acs.jmedchem.1c01687 |
| None |
No relevant target |
Solubility |
5.2 |
ug.mL-1 |
10.1016/s0960-894x(98)00145-0 |
| None |
No relevant target |
Solubility |
42400.0 |
nM |
10.1039/C2MD20266B |
| None |
T-cell |
IC50 |
0.18 |
nM |
10.1016/S0960-894X(01)81248-8 |
| None |
T-cell |
IC50 |
0.29 |
nM |
10.1016/S0960-894X(01)80264-X |
| None |
T-cell |
IC50 |
0.5 |
nM |
10.1021/jm00008a001 |
| None |
T-cell |
IC50 |
0.9 |
nM |
10.1021/jm00008a001 |
| None |
T-cell |
T-cell |
0.3 |
nM |
10.1021/jm9806042 |
| None |
Unchecked |
Activity |
2.61 |
None |
10.1021/acs.jnatprod.0c00767 |
| None |
Unchecked |
Hepatotoxicity (acute) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
2.7e-05 |
ug.mL-1 |
10.1021/acs.jnatprod.9b00144 |
| None |
Unchecked |
IC50 |
0.056 |
nM |
10.1039/C2MD20266B |
| None |
Unchecked |
IC50 |
0.19 |
nM |
10.1021/jm031101l |
| None |
Unchecked |
IC50 |
0.39 |
nM |
10.1021/jm9806042 |
| None |
Unchecked |
IC50 |
0.4 |
nM |
10.1016/j.bmcl.2020.127545 |
| None |
Unchecked |
IC50 |
0.4 |
nM |
10.1021/acs.jmedchem.1c00631 |
| None |
Unchecked |
IC50 |
0.5 |
nM |
10.1021/jm010066k |
| None |
Unchecked |
IC50 |
1.0 |
nM |
10.1016/S0960-894X(01)80137-2 |
| None |
Unchecked |
IC50 |
2.0 |
nM |
10.1016/j.bmcl.2020.127545 |
| None |
Unchecked |
IC50 |
2.54 |
nM |
10.1016/s0960-894x(98)00145-0 |
| None |
Unchecked |
IC50 |
11.1 |
nM |
10.1021/jm9806042 |
| None |
Unchecked |
IC50 |
18.45 |
nM |
10.1016/j.bmcl.2017.04.004 |
| None |
Unchecked |
IC50 |
2260.0 |
nM |
10.1021/jm0707424 |
| None |
Unchecked |
IC50 |
nan |
None |
10.1021/jm010066k |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/ml400306r |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/np1006247 |
| None |
Unchecked |
Inhibition |
nan |
% |
None |
| None |
Unchecked |
Ki |
33.0 |
nM |
10.1016/j.pharmthera.2004.10.013 |
| None |
Unchecked |
Ki |
35.0 |
nM |
10.1021/jm031101l |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Log Kd |
-9.7 |
None |
10.1021/jm0105833 |
| None |
Unchecked |
Potency |
6309.6 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
25574.8 |
nM |
None |
| None |
Unchecked |
Ratio |
0.0 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.001 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
rIC50 |
1.0 |
None |
10.1016/s0960-894x(98)00702-1 |
| None |
Unchecked |
Therapeutic index |
17.0 |
None |
10.1016/s0960-894x(99)00336-4 |